Amniox Medical Announces Study Confirming Superiority Of Proprietary Cryopreservation Technology For Processing Umbilical Cord & Amniotic Membrane Tissue

ATLANTA--(BUSINESS WIRE)--Amniox Medical, Inc., a developer and marketer of regenerative therapies processed from umbilical cord and amniotic membrane, announces the publication of Comparison of Cryopreserved Amniotic Membrane and Umbilical Cord Tissue with Dehydrated Amniotic Membrane/Chorion Tissue in the October edition of the Journal of Wound Care. This study directly compares the CRYOTEK® preservation method with the PURION® (dehydration) processing method and demonstrates the following conclusions:

• Cryopreservation retains the native architecture of the amniotic membrane (AM)/umbilical cord (UC) extracellular matrix. Dehydration dramatically compacts the tissue, suggesting alteration of critical components within.

Help employers find you! Check out all the jobs and post your resume.